Related references
Note: Only part of the references are listed.Knockdown of YAP/TAZ sensitizes tamoxifen-resistant MCF7 breast cancer cells
Yu Jin Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers
Federica Lo Sardo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2022)
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis
Ruize Gao et al.
EMBO MOLECULAR MEDICINE (2021)
Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
Yunxia Cui et al.
FRONTIERS IN ONCOLOGY (2021)
Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma
Xiaohong Ma et al.
CELL DEATH & DISEASE (2021)
Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma
Taohui Ouyang et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
Rui Liu et al.
CELL DEATH & DISEASE (2020)
Endometrial Cancer
Karen H. Lu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma
Qing Zhou et al.
CANCER MEDICINE (2019)
The Role of Nrf2 Activity in Cancer Development and Progression
Alina-Andreea Zimta et al.
CANCERS (2019)
YAP/TAZ Signaling and Resistance to Cancer Therapy
Chan D. K. Nguyen et al.
TRENDS IN CANCER (2019)
Roles of SIRT1/FoxO1/SREBP-1 in the development of progestin resistance in endometrial cancer
Yilin Wang et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2018)
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
Oleg Dobrokhotov et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer
Shuai Chen et al.
MOLECULAR CANCER (2017)
PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy
Hua Liu et al.
ONCOTARGETS AND THERAPY (2017)
YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway
Chao Wang et al.
CANCER RESEARCH (2017)
Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex
Honglong Wei et al.
CANCER SCIENCE (2017)
Snail/Slug binding interactions with YAP/TAZ control skeletal stem cell self-renewal and differentiation
Yi Tang et al.
NATURE CELL BIOLOGY (2016)
Functional and Clinical Evidence That TAZ is a Candidate Oncogene in Hepatocellular Carcinoma
Yan Guo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer
Laura Romero-Perez et al.
MODERN PATHOLOGY (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
An Integrative Analysis of the Tumorigenic Role of TAZ in Human Non-Small Cell Lung Cancer
Satoshi Noguchi et al.
CLINICAL CANCER RESEARCH (2014)
Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis
Allison N. Lau et al.
EMBO JOURNAL (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
Yes-Associated Protein (YAP) Modulates Oncogenic Features and Radiation Sensitivity in Endometrial Cancer
Masahiro Tsujiura et al.
PLOS ONE (2014)
The Hippo Transducer TAZ Interacts with the SWI/SNF Complex to Regulate Breast Epithelial Lineage Commitment
Adam Skibinski et al.
CELL REPORTS (2014)
Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma
Su-xia Han et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Role of LPA and the Hippo pathway on apoptosis in salivary gland epithelial cells
Sung-Min Hwang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)
Jeong-Yeol Park et al.
EUROPEAN JOURNAL OF CANCER (2013)
Lives in the Balance: Women With Cancer and the Right to Fertility Care
Clarisa R. Gracia et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Systemic and Local Hormone Therapy for Endometrial Hyperplasia and Early Adenocarcinoma
Jessica L. Hubbs et al.
OBSTETRICS AND GYNECOLOGY (2013)
Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate
Shunjun Zhao et al.
ONCOLOGY LETTERS (2013)
Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer
Eva J. Vlug et al.
CELLULAR ONCOLOGY (2013)
Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review
Camille C. Gunderson et al.
GYNECOLOGIC ONCOLOGY (2012)
Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-related Macular Degeneration Twelve-month MONT BLANC Study Results
Michael Larsen et al.
OPHTHALMOLOGY (2012)
Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer
Chao Gu et al.
CANCER SCIENCE (2011)
Conservative Treatment With Progestin and Pregnancy Outcomes in Endometrial Cancer
Ho-Suap Hahn et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women
Kimio Ushijima et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
From cell structure to transcription: Hippo forges a new path
BA Edgar
CELL (2006)
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP
JB Huang et al.
CELL (2005)
Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia - precursor of endometrial cancer
S Wang et al.
GYNECOLOGIC ONCOLOGY (2003)
Share Paper
